Примери за използване на Authorisation application на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Withdrawal of the marketing authorisation application for Raxone(idebenone).
The following main studies were submitted by the applicant in support of the marketing authorisation application.
Withdrawal of the marketing authorisation application for Fyzoclad(adalimumab).
The failures identified were such that the data provided by the company could not be used to evaluate the marketing authorisation application.
Withdrawal of the marketing authorisation application for Xegafri(rociletinib).
Хората също превеждат
Additional supportive data, where appropriate, shall be referenced to the relevant chapters of Module 4(Non Clinical Study Reports) and Module 5(Clinical Study Reports)of the marketing authorisation application dossier.
Withdrawal of the marketing authorisation application for Winfuran(nalfurafine).
Further measures to minimise the risk of infection should also be carried forward to clinical practice,including those used in studies supporting the initial marketing authorisation application with favourable results.
Withdrawal of the marketing authorisation application for Jenzyl(ridaforolimus).
The company plans to include these data in a new marketing authorisation application in the EU.
A parallel import authorisation application shall contain at least the following information.
FSM NORMA shall take all the necessary steps to ensure that the data received as part of the fishing authorisation application are treated as confidential.
Withdrawal of the marketing authorisation application for Graspa(L-asparaginase).
An import authorisation application as referred to in Article 56a(1)(c) shall be submitted to the Agency.
Dated 7 December 2007 of the Risk Management Plan(RMP)presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP.
Withdrawal of the marketing authorisation application for Emerflu[pandemic influenza vaccine(H5N1)(split virion, inactivated, adjuvanted)].
The harmonization of the pharmacokinetic section in the teicoplanin SmPC is based on the data first provided in the initial marketing authorisation application, and more recent data retrieved from a literature research.
Withdrawal of the marketing authorisation application for Comfyde(carisbamate) EMA/32301/2010.
An import authorisation application as referred to in Article 56a(1)(b) shall be submitted to the competent authority of the Member State of the importer.
The MAH must ensure that the system of pharmacovigilance,as described in Part 1 of the marketing authorisation application, is in place and functioning before and whilst the product is on the market.
The decentralised marketing authorisation application was submitted under Article 28(3) of Directive 2001/83/EC in accordance with Article 10b of Directive 2001/83/EC.
Developing your translation strategy as early as possible will allow adequate time for a Language Service Provider to familiarise itself with the needs of your company, your authorisation application, and any modifications that need to occur in the application while the process is in its initial English-only stages.
The Applicant submitted a marketing authorisation application for Glimepirida Parke-Davis, based on claims of essential similarity to the marketed reference product.
Withdrawal of the marketing authorisation application for Corluxin(mifepristone).
The marketing authorisation application(MAA) for Myoson was submitted under Article 10(1) of Directive 2001/83/EC(i.e. a generic application), vis-à-vis the reference medicinal product Mydeton(Gedeon Richter Plc).
The MAH also provided details of 4 bio-equivalence studies,conducted to support the marketing authorisation application in the United States and Canada, comparing Leflunomide Apotex with their reference product, under fasting and fed conditions.
Of the five pivotal studies submitted with this Marketing Authorisation Application three studies were designed such that they facilitate a rigorous, internally validated examination as to whether the long-acting β2 agonist formoterol fumarate“masks” deficient corticosteroid effects of Iffeza upon pre-dose FEV1.
Withdrawal of the marketing authorisation application for Cavoley(pegfilgrastim).
The legal basis for the submitted marketing authorisation application(MAA) was Article 10a"well established use", relying on appropriate scientific literature data of another similar product, Nanocoll.
Withdrawal of the marketing authorisation application for Neofordex(dexamethasone).